AngioDynamics, Inc. — Revenue by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3613c7df-46ec-43e4-8ca1-7e057e42e216/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $320.2M | 2025-06-01 – 2026-05-31 | evidence 0001628280-26-048138 |
| FY 2024 | $292.5M | 2024-06-01 – 2025-05-31 | evidence 0001275187-25-000014 |
| FY 2023 | $303.9M | 2023-06-01 – 2024-05-31 | evidence 0001628280-24-032989 |
| FY 2022 | $338.8M | 2022-06-01 – 2023-05-31 | evidence 0001628280-23-027335 |
| FY 2021 | $316.2M | 2021-06-01 – 2022-05-31 | evidence 0001275187-22-000017 |
| FY 2020 | $291.0M | 2020-06-01 – 2021-05-31 | evidence 0001275187-22-000017 |
| FY 2019 | $264.2M | 2019-06-01 – 2020-05-31 | evidence 0001275187-22-000017 |
| FY 2018 | $270.6M | 2018-06-01 – 2019-05-31 | evidence 0001275187-19-000017 |
| FY 2017 | $261.7M | 2017-06-01 – 2018-05-31 | evidence 0001275187-19-000017 |
| FY 2016 | $269.8M | 2016-06-01 – 2017-05-31 | evidence 0001275187-19-000017 |
| FY 2015 | $353.9M | 2015-06-01 – 2016-05-31 | evidence 0001275187-18-000011 |
| FY 2014 | $356.5M | 2014-06-01 – 2015-05-31 | evidence 0001275187-16-000034 |
| FY 2013 | $354.4M | 2013-06-01 – 2014-05-31 | evidence 0001445305-14-004301 |
| FY 2012 | $341.9M | 2012-06-01 – 2013-05-31 | evidence 0001445305-14-004301 |
| FY 2011 | $221.9M | 2011-06-01 – 2012-05-31 | evidence 0001445305-14-004301 |
| FY 2010 | $215.6M | 2010-06-01 – 2011-05-31 | evidence 0001445305-14-004301 |
| FY 2009 | $216.0M | 2009-06-01 – 2010-05-31 | evidence 0001193125-12-355457 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AngioDynamics, Inc. — all facts · Net Income · Operating Income